# Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions

> **NCT01331434** · NA · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 47 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** exemestane

## Key facts

- **NCT ID:** NCT01331434
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331434, "Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01331434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*